Bloomberg @business
Moderna’s influenza vaccine had mixed results in a final-stage trial, raising questions about its plan to seek US approval for a shot based on its messenger RNA technology https://t.co/0HGVdOnZaU — PolitiTweet.org
Created
Thu Feb 16 22:18:51 +0000 2023
Likes
21
Retweets
14
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Bloomberg @business
Moderna’s influenza vaccine had mixed results in a final-stage trial, raising questions about its plan to seek US approval for a shot based on its messenger RNA technology https://t.co/0HGVdOnZaU — PolitiTweet.org